| Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns—NHANES 2007–2012 B Wu, K Bell, A Stanford, DM Kern, O Tunceli, S Vupputuri, I Kalsekar, ... BMJ Open Diabetes Research and Care 4 (1), e000154, 2016 | 195 | 2016 |
| Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation ED Peterson, V Ashton, YW Chen, B Wu, AC Spyropoulos American heart journal 212, 113-119, 2019 | 84 | 2019 |
| Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costs AC Spyropoulos, V Ashton, YW Chen, B Wu, ED Peterson Thrombosis research 182, 159-166, 2019 | 58 | 2019 |
| Risk of childhood wheeze and asthma after respiratory syncytial virus infection in full‐term infants A Mejias, B Wu, N Tandon, W Chow, R Varma, E Franco, O Ramilo Pediatric Allergy and Immunology 31 (1), 47-56, 2020 | 40 | 2020 |
| Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller … DM Kern, J Davis, SA Williams, O Tunceli, B Wu, S Hollis, C Strange, ... Respiratory research 16, 1-12, 2015 | 40 | 2015 |
| Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US Population JR Davis, B Wu, DM Kern, O Tunceli, KM Fox, J Horton, RF Legg, F Trudo American Health & Drug Benefits 10 (2), 92, 2017 | 37 | 2017 |
| Applying weighting methodologies to a commercial database to project US Census demographic data T Wasser, B Wu, WY Joseph, O Tunceli MJH Life Sciences, 2015 | 34 | 2015 |
| Assessment of Outpatient and Inpatient Antibiotic Treatment Patterns and Health Care Costs of Patients with Complicated Urinary Tract Infections RM Turner, B Wu, K Lawrence, J Hackett, S Karve, O Tunceli Clinical therapeutics 37 (9), 2037-2047, 2015 | 33 | 2015 |
| Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population DM Kern, J Davis, SA Williams, O Tunceli, B Wu, S Hollis, C Strange, ... International journal of chronic obstructive pulmonary disease, 1417-1425, 2015 | 32 | 2015 |
| Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies VJ Willey, S Kong, B Wu, A Raval, T Hobbs, A Windsheimer, ... American Health & Drug Benefits 11 (6), 310, 2018 | 28 | 2018 |
| Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population DM Kern, C Mellström, PR Hunt, O Tunceli, B Wu, M Westergaard, ... Current medical research and opinion 32 (4), 703-711, 2016 | 26 | 2016 |
| Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis Q Cai, A Teeple, B Wu, E Muser Journal of medical economics 22 (12), 1290-1297, 2019 | 24 | 2019 |
| Brain metastases in non-small cell lung cancer patients on epidermal growth factor receptor tyrosine kinase inhibitors: symptom and economic burden AW Fernandes, B Wu, RM Turner Journal of Medical Economics 20 (11), 1136-1147, 2017 | 21 | 2017 |
| Treatment adherence and persistence of five commonly prescribed medications for moderate to severe psoriasis in a US commercially insured population B Wu, E Muser, A Teeple, CD Pericone, SR Feldman Journal of Dermatological Treatment 32 (6), 595-602, 2021 | 17 | 2021 |
| A real-world analysis of glycemic control among patients with type 2 diabetes treated with canagliflozin versus dapagliflozin L Blonde, C Patel, B Bookhart, M Pfeifer, YW Chen, B Wu Current medical research and opinion 34 (6), 1143-1152, 2018 | 16 | 2018 |
| Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns—NHANES 2007-2012. BMJ Open Diabetes Res Care 2016; 4: e000154 B Wu, K Bell, A Stanford, DM Kern, O Tunceli, S Vupputuri Epub 2016/04/26, 2016 | 15 | 2016 |
| Total cost of care for castration-resistant prostate cancer in a commercially insured population and a medicare supplemental insured population B Wu, SS Li, J Song, CD Pericone, AS Behl, NA Dawson Journal of medical economics 23 (1), 54-63, 2020 | 14 | 2020 |
| Health care utilization and costs after initiating budesonide/formoterol combination or fluticasone/salmeterol combination among COPD patients new to ICS/LABA treatment JR Davis, DM Kern, SA Williams, O Tunceli, B Wu, S Hollis, C Strange, ... Journal of managed care & specialty pharmacy 22 (3), 293-304, 2016 | 14 | 2016 |
| Cost of care for patients with metastatic castration-resistant prostate cancer initiating on docetaxel versus oral targeted therapies in the United States. B Wu, S Li, O Tunceli, J Song, C Pericone, Z Ding, AS Behl, A Srivastava, ... Journal of Clinical Oncology 36 (30_suppl), 88-88, 2018 | 12 | 2018 |
| A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data DM Kern, JJ Barron, B Wu, A Ganetsky, VJ Willey, RA Quimbo, MJ Fisch, ... Pragmatic and Observational Research, 149-155, 2017 | 12 | 2017 |
Professor Sally HollisUniversity of ManchesterBestätigte E-Mail-Adresse bei manchester.ac.uk
